Pasithea Therapeutics Revenue vs. Current Ratio
| KTTAW Stock | USD 0.02 0 11.11% |
Total Revenue | First Reported 2010-12-31 | Previous Quarter 559.5 K | Current Value 362.3 K | Quarterly Volatility 191.9 K |
For Pasithea Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Pasithea Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Pasithea Therapeutics Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Pasithea Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Pasithea Therapeutics Corp over time as well as its relative position and ranking within its peers.
Pasithea |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pasithea Therapeutics. If investors know Pasithea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pasithea Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.37 | Return On Assets (0.38) | Return On Equity (0.63) |
The market value of Pasithea Therapeutics is measured differently than its book value, which is the value of Pasithea that is recorded on the company's balance sheet. Investors also form their own opinion of Pasithea Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Pasithea Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pasithea Therapeutics' market value can be influenced by many factors that don't directly affect Pasithea Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pasithea Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pasithea Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pasithea Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pasithea Therapeutics Current Ratio vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Pasithea Therapeutics's current stock value. Our valuation model uses many indicators to compare Pasithea Therapeutics value to that of its competitors to determine the firm's financial worth. Pasithea Therapeutics Corp is rated below average in revenue category among its peers. It is currently regarded as number one stock in current ratio category among its peers . The ratio of Revenue to Current Ratio for Pasithea Therapeutics Corp is about 12,958 . At this time, Pasithea Therapeutics' Total Revenue is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Pasithea Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Pasithea Revenue vs. Competition
Pasithea Therapeutics Corp is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 378.39 Million. Pasithea Therapeutics adds roughly 486,559 in revenue claiming only tiny portion of equities under Health Care industry.
Pasithea Current Ratio vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Pasithea Therapeutics |
| = | 486.56 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Pasithea Therapeutics |
| = | 37.55 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Pasithea Current Ratio Comparison
Pasithea Therapeutics is currently under evaluation in current ratio category among its peers.
Pasithea Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Pasithea Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pasithea Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Pasithea Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Pasithea Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4.7 K | -4.9 K | |
| Operating Income | -16 M | -15.2 M | |
| Income Before Tax | -15.5 M | -14.7 M | |
| Total Other Income Expense Net | 471.6 K | 733.3 K | |
| Net Loss | -15.5 M | -14.7 M | |
| Income Tax Expense | 453.9 M | 476.6 M | |
| Net Interest Income | 242.4 K | 254.6 K | |
| Net Loss | -16.7 M | -17.6 M | |
| Interest Income | 415.4 K | 228.5 K | |
| Net Loss | (12.65) | (13.28) | |
| Net Income Per E B T | 1.03 | 0.79 |
Pasithea Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Pasithea Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pasithea Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pasithea Therapeutics' important profitability drivers and their relationship over time.
Use Pasithea Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pasithea Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will appreciate offsetting losses from the drop in the long position's value.Pasithea Therapeutics Pair Trading
Pasithea Therapeutics Corp Pair Trading Analysis
The ability to find closely correlated positions to Pasithea Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pasithea Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pasithea Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pasithea Therapeutics Corp to buy it.
The correlation of Pasithea Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pasithea Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pasithea Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pasithea Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Pasithea Therapeutics position
In addition to having Pasithea Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recycling Thematic Idea Now
Recycling
West management companies as well as entities specializing in pollution control and recycling. The Recycling theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recycling Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Pasithea Stock Analysis
When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.